Navigation Links
Shengtai Pharmaceutical, Inc. to Present at Roth Conference
Date:2/7/2008

WEIFANG, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced its CFO, Mr. Yizhao Zhang, will present at the upcoming Roth 20th Annual OC Growth Stock Conference in Dana Point, California.

The date, time and location of Shengtai Pharmaceutical, Inc.'s presentation at the conference are as follows:

Date: Thursday, February 21, 2008

Time: 10:30 a.m. Pacific Time

Venue: Ritz Ballroom Salon 1

The Ritz Carlton Laguna Niguel

One Ritz-Carlton Drive

Dana Point, California 92629

Webcast: http://www.wsw.com/webcast/roth16/sgti/

A replay of the call will be available for 90 days following the presentation using the same link and will also be available on the Company's website.

The ROTH 20th Annual OC Conference will feature presentations from over 300 small-cap companies including over 40 U.S.-listed Chinese companies. The distinguished list of presenting companies have been identified by Roth Capital's award-winning research team and are representative of a broad spectrum of sectors, including Technology, Healthcare, Energy and Industrial as well as Consumer Products.

Interested parties and investors may find more information for the conference by visiting the website at http://www.rothcapital.com.

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the holding company for Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutic
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
4. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
5. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
6. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
7. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...eyed MCO Pharmacy Directors Will Move Razadyne and...zadyne is Launched, According to a New ... Mass., July 9 /PRNewswire/ -- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi.../Ortho McNeil,s Razadyne (galantamine) in December...
(Date:7/9/2008)...ve day OnBase deployment critical in electronic he...t patients, CLEVELAND, July 9 /PRNewswire/ -- Hyl...e document management software suite, announced th...ts since the deployment of,OnBase in March. Based ...ur,states, SSM is a forward-thinking health care p...
(Date:7/9/2008)..., July 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX: M... services to the global life,sciences markets, tod...anada Limited (AECL) with notice of arbitration pr...AECL to fulfill its contractual obligations,under ...LTSA) and if not,granted, seeking significant mone...
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
Breaking Medicine News(10 mins):Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...ir findings in the current Biology online on Febru...f a protein that plays// key roles in the control ...hibitor can halt the growth of tumors in mice and ...e. The findings are reported in companion papers...
...latest issue of the medical journal The Lancet cla...fects on arthritics//. This research carried out b...ience Foundation independently. Patients sufferin...oidal anti-inflammatories (NSAIDS) like Aspirin an...
...ucted by British researchers, breast fed babies ha...ed counterparts//. This once again goes on to prov...tudy was conducted by Institute of Child Health in...group of four to six. In this group, 184 children...
...vasively identify women at risk for preterm birth,...tal adrenal glands//, according to an abstract pre...he Society for Maternal-Fetal Medicine Conference ... major public health problem with lasting repercus...
Other Medicine News:Health News:New Protein Inhibitor Halts Growth Of Cancerous Cells 2
(Date:7/7/2008)...Newswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bull...ed biopharmaceutical,company specializing in the p...day provided an operational update on the company,...uman clinical trial testing and,plans to proceed i.... Five,successful human trials evaluating GeoVax A...
(Date:7/7/2008)...uly 7 /- Biopure Corporatio... discussions with the Food,and Drug Administration...tion for a new clinical trial of Hemopure(R) [hemo...ure has proposed to study use of Hemopure,in patie...) who refuse,transfusion with blood components. Cu...
(Date:7/7/2008)...ests Kiwifruit is Top Performer in the Body, SEAT...ated equal when,it comes to their antioxidant powe...bioavailability compared to other antioxidant-rich...published in the Journal of the,American College o...hytochemicals called flavonoids that,may have the ...
(Date:7/6/2008)...CTI,s Marketing Authorization Application currentl... SEATTLE, July 7 /- Cell T...y announced the publication of results from its,ra...litaxel poliglumex,CT-2103) with gemcitabine or v...status 2) patients with previously untreated non-s...
Breaking Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 1UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 2UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 3Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 1Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 2Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 3Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 1Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 2Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 3MSA Schedules Third Quarter Earnings Webcast 4482 1MSA Schedules Third Quarter Earnings Webcast 4482 2
... NEW YORK--(BUSINESS WIRE)--May 30, 2007 - INNOVIV...ced that interim data from a Phase I,trial of INNO...kinase inhibitor for Gleevec(R)-resistant or,treat... be,presented at the 43rd American Society of Clin...ace June 1- 5, 2007 at McCormick Place,in Chicago,...
... PALO ALTO, Calif., May 31, 2007 /PRNewswire-Firs...oday that it will present at the,49th Annual Ameri...e IIb clinical trial of Staccato(R) prochlorperazi...adache. The poster,presentation, "Efficacy and tol...zine) in patients with migraine headache",(Poster ...
Other Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
...ecifically to enable direct inspection of the peri... applications as well. Its insertion tube and dist...nsertion into the peripheral bronchi can be accomp...ated scope offers high-resolution and brightness, ...
Double lumen tubes for selective one-lung ventilation., ,Each SHER-I-BRONCH Endobronchial Tube is packaged with pre-loaded stylet, tube-to-circuit adaptors, suction catheters and Accessories Pack (f
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
...tablish emergency airway access through the cricot...s a 12 gauge x 3" Angiocath I.V. catheter, which i...to ventilate. Designed to be used with the liter f...milar to the Cook Emergency Cricothyrotomy Kit, bu...
Medicine Products: